Adjuvant immunotherapy for high‐risk renal cell carcinoma—now or never?

IF 3.7 2区医学 Q1 UROLOGY & NEPHROLOGY

BJU International Pub Date : 2024-11-08 DOI:10.1111/bju.16584

Tivya Kulasegaran, Niara Oliveira, Craig Gedye, Shomik Sengupta

引用次数: 0

Abstract

Click on the article title to read more.

查看原文本刊更多论文

高危肾细胞癌的辅助免疫疗法--现在还是永远？

点击文章标题阅读更多内容。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BJU International 医学-泌尿学与肾脏学

CiteScore

9.10

自引率

4.40%

发文量

262

审稿时长

1 months

期刊介绍： BJUI is one of the most highly respected medical journals in the world, with a truly international range of published papers and appeal. Every issue gives invaluable practical information in the form of original articles, reviews, comments, surgical education articles, and translational science articles in the field of urology. BJUI employs topical sections, and is in full colour, making it easier to browse or search for something specific.